The cases of monkeypox currently detected do not necessarily show the usual symptoms, which can make it difficult to diagnose, American health officials warned on Friday June 10, 2022, stressing that identifying these cases is crucial to stop the spread of the disease contain disease. .
“We have seen mild cases of monkeypox, sometimes confined to certain parts of the body, which is different from what usually occurs in countries where the disease is endemic.” in Africa, Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), said on Friday.
“This has raised concerns that some cases are going undetected”she stressed, urging the public and healthcare professionals to be extra vigilant.
Current cases do not always present with the flu-like symptoms (fever, etc.) that usually precede the appearance of the rashes characteristic of this disease.
We have blocked this content from being displayed to respect your cookie choices.
By clicking “Consult” you accept the deposit of cookies by social networking services such as Twitter.
To hear that #monkeypox spreads through the air? Not known to linger in the air. It is not transmitted during short periods of shared airspace. It spreads through contact with someone with monkeypox. It can also spread when people have close personal contact. https://t.co/wjXyL7Fa3G
— CDC (@CDCgov) June 9, 2022
Although these rashes usually appear all over the body, many of the current cases are localized to specific areas.
“It is important to realize that cases of monkeypox can resemble certain sexually transmitted infections”like herpes, “and could therefore be misdiagnosed”Mrs. Walensky pointed out.
Closer and longer contact
The United States now has 45 registered cases, she added, double the number last week. No deaths were reported.
As of June 9, around 1,300 cases had been identified worldwide, she said.
Transmission requires close and prolonged contact between two people.
In particular, the USA is relying on the vaccination of contact cases to contain the epidemic.
The country has 100 million doses of ACAM2000 but is in the process of receiving doses of another more modern vaccine, Jynneos.
At the end of May, the United States had just 1,000 doses of this second drug, compared to 72,000 today, the US Department of Health and Human Services Dawn O’Connell said Friday. And another 300,000 doses are expected to arrive in the coming weeks, she added.